Press Releases

November 15, 2017
Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors
November 01, 2017
Moderna Announces New Collaboration with AstraZeneca to Co-Develop and Co-Commercialize Relaxin mRNA Therapeutic for Heart Failure
October 19, 2017
Moderna Named One of Global Biopharmaceutical Industry’s Top Employers in Science Magazine’s Annual Survey
October 10, 2017
Stephen Berenson Joins Moderna’s Board of Directors
September 26, 2017
Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines
September 14, 2017
Moderna Announces Pipeline and Corporate Update
August 03, 2017
Industry Veteran Juan Andres Joins Moderna as Senior Vice President of Late Stage Technical Development and Manufacturing
July 27, 2017
Moncef M. Slaoui, Ph.D. Joins Moderna’s Board of Directors
July 27, 2017
Moderna Provides Update on mRNA Rare Disease Research and Development Strategy
July 13, 2017
Publication in Cell Demonstrates Moderna’s Zika mRNA Vaccine Prevents In Utero Transmission of Zika Virus in Mice, Protects Against Zika-Related Congenital Damage

Media Coverage

Endpoints News
September 14, 2017

AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans

FiercePharma
September 14, 2017

Moderna initiates Chikungunya vaccine human test, replaces backup Zika candidate

Reuters News
September 14, 2017

Moderna, AstraZeneca heart drug succeeds early-stage trial

Endpoints News
August 03, 2017

Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech

FiercePharma
August 03, 2017

Moderna brings on former Novartis exec to oversee manufacturing of mRNA therapies

Boston Business Journal
August 03, 2017

Moderna taps Novartis exec to lead manufacturing blitz

BioPharma-Reporter.com
June 07, 2017

‘Don’t underestimate Merck’s vaccine business,’ says CEO

CNBC
May 16, 2017

Meet the 2017 CNBC Disruptor 50 Companies

Wall Street Journal
April 27, 2017

Startup Moderna Shows Promise in Vaccine Trial

Huffington Post
April 21, 2017

The Immunization ‘Innovations of Tomorrow’ Are Here Today